Literature DB >> 24440939

Long-term survival of fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: a US population-based study.

Basile Njei1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24440939      PMCID： PMC4822547          DOI： 10.1097/MCG.0000000000000070

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  3 in total

1.  Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.

Authors:  Sanjay Kakar; Lawrence J Burgart; Kenneth P Batts; Joaquin Garcia; Dhanpat Jain; Linda D Ferrell
Journal:  Mod Pathol       Date:  2005-11       Impact factor: 7.842

2.  Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.

Authors:  Arndt Weinmann; Sandra Koch; Ina M Niederle; Henning Schulze-Bergkamen; Jochem König; Maria Hoppe-Lotichius; Torsten Hansen; Michael B Pitton; Christoph Düber; Gerd Otto; Marcus Schuchmann; Peter R Galle; Marcus A Wörns
Journal:  J Clin Gastroenterol       Date:  2014-03       Impact factor: 3.062

3.  Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.

Authors:  Hashem B El-Serag; Jessica A Davila
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425
  3 in total
  2 in total

1.  mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.

Authors:  Kimberly J Riehle; Matthew M Yeh; Jeannette J Yu; Heidi L Kenerson; William P Harris; James O Park; Raymond S Yeung
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

2.  Duodenal Recurrence of Fibrolamellar Carcinoma 12 Years After Partial Hepatectomy and Adjuvant Chemotherapy.

Authors:  Héctor Adrián Díaz Hernández; Ismael Antonio Gómez Ruiz; Aldo Torre
Journal:  ACG Case Rep J       Date:  2016-11-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.